343 related articles for article (PubMed ID: 19149855)
1. Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?
Salvagno GL; Astermark J; Lippi G; Ekman M; Franchini M; Guidi GC; Berntorp E
Haemophilia; 2009 Jan; 15(1):290-6. PubMed ID: 19149855
[TBL] [Abstract][Full Text] [Related]
2. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
Gilmore R; Harmon S; Gannon C; Byrne M; O'Donnell JS; Jenkins PV
Haemophilia; 2010 Jul; 16(4):671-4. PubMed ID: 20148980
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation and phenotypic correlation in haemophilia A.
Beltrán-Miranda CP; Khan A; Jaloma-Cruz AR; Laffan MA
Haemophilia; 2005 Jul; 11(4):326-34. PubMed ID: 16011583
[TBL] [Abstract][Full Text] [Related]
4. Impact of different inhibitor reactivities with commercial factor VIII concentrates on thrombin generation.
Salvagno GL; Astermark J; Ekman M; Franchini M; Guidi GC; Lippi G; Poli G; Berntorp E
Haemophilia; 2007 Jan; 13(1):51-6. PubMed ID: 17212725
[TBL] [Abstract][Full Text] [Related]
5. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion.
Lewis SJ; Stephens E; Florou G; Macartney NJ; Hathaway LS; Knipping J; Collins PW
Br J Haematol; 2007 Sep; 138(6):775-82. PubMed ID: 17672884
[TBL] [Abstract][Full Text] [Related]
6. Validation of a procedure for potency assessing of a high purity factor VIII concentrate--comparison of different factor VIII coagulant assays and effect of prediluent.
Mazurier C; Parquet-Gernez A; Goudemand M
Thromb Haemost; 1990 Oct; 64(2):251-5. PubMed ID: 2125374
[TBL] [Abstract][Full Text] [Related]
7. Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters.
van Veen JJ; Gatt A; Cooper PC; Kitchen S; Bowyer AE; Makris M
Blood Coagul Fibrinolysis; 2008 Apr; 19(3):183-9. PubMed ID: 18388496
[TBL] [Abstract][Full Text] [Related]
8. In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results.
Rodgers SE; Duncan EM; Barbulescu DM; Quinn DM; Lloyd JV
Br J Haematol; 2007 Jan; 136(1):138-45. PubMed ID: 17222201
[TBL] [Abstract][Full Text] [Related]
9. Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A.
van Veen JJ; Gatt A; Bowyer AE; Cooper PC; Kitchen S; Makris M
Thromb Res; 2009 Apr; 123(6):895-901. PubMed ID: 19012951
[TBL] [Abstract][Full Text] [Related]
10. Functional characteristics of N8, a new recombinant FVIII.
Christiansen ML; Balling KW; Persson E; Hilden I; Bagger-Sørensen A; Sørensen BB; Viuff D; Segel S; Klausen NK; Ezban M; Lethagen S; Steenstrup TD; Kjalke M
Haemophilia; 2010 Nov; 16(6):878-87. PubMed ID: 20546031
[TBL] [Abstract][Full Text] [Related]
11. Influence of factor VIII on overall coagulability and fibrinolytic potential of haemophilic plasma as measured by global assay: monitoring in haemophilia A.
Goldenberg NA; Hathaway WE; Jacobson L; McFarland K; Manco-Johnson MJ
Haemophilia; 2006 Nov; 12(6):605-14. PubMed ID: 17083510
[TBL] [Abstract][Full Text] [Related]
12. Platelets significantly modify procoagulant activities in haemophilia A.
Wartiovaara-Kautto U; Joutsi-Korhonen L; Ilveskero S; Armstrong E; Lassila R
Haemophilia; 2011 Sep; 17(5):743-51. PubMed ID: 21682825
[TBL] [Abstract][Full Text] [Related]
13. Thrombomodulin-modified thrombin generation after in vivo recombinant factor VIII treatment in severe hemophilia A.
Dielis AW; Balliël WM; van Oerle R; Hermens WT; Spronk HM; Ten Cate H; Hamulyák K
Haematologica; 2008 Sep; 93(9):1351-7. PubMed ID: 18641016
[TBL] [Abstract][Full Text] [Related]
14. Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.
Pavlova A; Delev D; Pezeshkpoor B; Müller J; Oldenburg J
Thromb Haemost; 2014 May; 111(5):851-61. PubMed ID: 24452774
[TBL] [Abstract][Full Text] [Related]
15. One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype.
Cid AR; Calabuig M; Cortina V; Casaña P; Haya S; Moret A; Cabrera N; Aznar JA
Haemophilia; 2008 Sep; 14(5):1049-54. PubMed ID: 18540892
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors.
Berntorp E; Figueiredo S; Futema L; Pock K; Knaub S; Walter O; Trawnicek L; Römisch J
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):577-83. PubMed ID: 20644466
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A.
Rodgers SE; Duncan EM; Sobieraj-Teague M; Lloyd JV
Int J Lab Hematol; 2009 Apr; 31(2):180-8. PubMed ID: 18190586
[TBL] [Abstract][Full Text] [Related]
18. Factor VIII test in reference preparations: compensation for different dilutions.
König H; Rosenkranz S; Nawrot R; Hunfeld A; Seitz R
Pharmeur Sci Notes; 2005 Aug; 2005(1):11-3. PubMed ID: 17687888
[TBL] [Abstract][Full Text] [Related]
19. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
[TBL] [Abstract][Full Text] [Related]
20. Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre.
Poulsen AL; Pedersen LH; Hvas AM; Poulsen LH; Thykjaer H; Ingerslev J
Haemophilia; 2009 Jan; 15(1):285-9. PubMed ID: 19149854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
